FDA Commissioner Asks Inspector General To Review Agency’s Aduhelm Approval

(July 12, 2021, 12:46 PM EDT) -- SILVER SPRING, Md. — Acting Food and Drug Administration Commissioner Janet W. Woodcock on July 9 ask the Department of Health and Human Services inspector general to conduct an independent review of interactions between drug maker Biogen and the FDA while the agency was considering whether to approve the Alzheimer’s drug Aduhelm....

Related Sections